Radiology, Vol 197, 517-523, Copyright © 1995 by Radiological Society of North America

ARTICLES

H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia

JM Constans, DJ Meyerhoff, J Gerson, S MacKay, D Norman, G Fein and MW Weiner
Magnetic Resonance Spectroscopy Unit, Department of Veterans Affairs Medical Center, San Francisco, CA 94121, USA.

PURPOSE: To investigate the association of white matter signal hyperintensities (WMSHs) with changes in hydrogen-1 metabolites. MATERIALS AND METHODS: T2-weighted magnetic resonance (MR) imaging and H-1 MR spectroscopic imaging were performed in 21 elderly control subjects without or with minimal WMSHs, eight elderly subjects with substantial WMSHs, 11 probable Alzheimer disease patients with WMSHs, and eight ischemic vascular dementia (IVD) patients with WMSHs. N- acetylaspartate (NAA), choline-containing metabolites (Cho), and creatine-containing metabolites (Cr) were analyzed. RESULTS: Differences in regional metabolite levels were found within the supraventricular brain of elderly control subjects. In Alzheimer disease patients, extensive WMSHs showed a lower percentage of NAA and a higher percentage of Cho compared with contralateral normal-appearing white matter (NAWM); in IVD patients, extensive and large WMSHs were associated with a higher percentage of Cho and a lower percentage of Cr compared with contralateral NAWM. CONCLUSION: Regional metabolite variation and the presence of WMSHs are important covariants that must be accounted for in analysis of MR spectroscopic data.

This article has been cited by other articles:

				P. E. Sijens, T. d. Heijer, D. Origgi, S. E. Vermeer, M. M. B. Breteler, A. Hofman, and M. Oudkerk Brain Changes with Aging: MR Spectroscopy at Supraventricular Plane Shows Differences between Women and Men Radiology, March 1, 2003; 226(3): 889 - 896. [Abstract] [Full Text] [PDF]

				J. R. Petrella, R. E. Coleman, and P. M. Doraiswamy Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future Radiology, February 1, 2003; 226(2): 315 - 336. [Abstract] [Full Text] [PDF]

				R. Squitti, D. Lupoi, P. Pasqualetti, G. Dal Forno, F. Vernieri, P. Chiovenda, L. Rossi, M. Cortesi, E. Cassetta, and P. M. Rossini Elevation of serum copper levels in Alzheimer's disease Neurology, October 22, 2002; 59(8): 1153 - 1161. [Abstract] [Full Text] [PDF]

				O. Kizu, K. Yamada, and T. Nishimura Proton Chemical Shift Imaging in Pick Complex AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1387 - 1392. [Abstract] [Full Text] [PDF]

				N. Schuff, A. A. Capizzano, A. T. Du, D. L. Amend, J. O'Neill, D. Norman, J. Kramer, W. Jagust, B. Miller, O. M. Wolkowitz, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD Neurology, March 26, 2002; 58(6): 928 - 935. [Abstract] [Full Text] [PDF]

				O. Kizu, K. Yamada, and T. Nishimura Proton Chemical Shift Imaging in Normal Pressure Hydrocephalus AJNR Am. J. Neuroradiol., October 1, 2001; 22(9): 1659 - 1664. [Abstract] [Full Text] [PDF]

				Y.-Y. Hsu, A.-T. Du, N. Schuff, and M. W. Weiner Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Dementias J Geriatr Psychiatry Neurol, September 1, 2001; 14(3): 145 - 166. [Abstract] [PDF]

				E. Angelie, A. Bonmartin, A. Boudraa, P.-M. Gonnaud, J.-J. Mallet, and D. Sappey-Marinier Regional Differences and Metabolic Changes in Normal Aging of the Human Brain: Proton MR Spectroscopic Imaging Study AJNR Am. J. Neuroradiol., January 1, 2001; 22(1): 119 - 127. [Abstract] [Full Text] [PDF]

				A. A. Capizzano, N. Schuff, D. L. Amend, J. L. Tanabe, D. Norman, A. A. Maudsley, W. Jagust, H. C. Chui, G. Fein, M. R. Segal, et al. Subcortical Ischemic Vascular Dementia: Assessment with Quantitative MR Imaging and 1H MR Spectroscopy AJNR Am. J. Neuroradiol., April 1, 2000; 21(4): 621 - 630. [Abstract] [Full Text]